Potential role of 1,25 (OH) 2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506
Mathieu, C.; Bouillon, R.; Rutgeerts, O.; Vandeputte, M.; Waer, M.
Transplantation Proceedings 26(6): 3130
1994
ISSN/ISBN: 0041-1345 PMID: 7527950 Document Number: 429871
Document emailed within 1 workday
Related Documents
Tanaka, I.; Oshima, H. 2007: Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis Clinical Calcium 17(11): 1738-1744Fogarty, M. 1993: Garlic's potential role in reducing heart disease British Journal of Clinical Practice 47(2): 64-65
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57
Sukhavasharin, N.; Praditpornsilpa, K.; Avihingsanon, Y.; Kuoatawintu, P.; O-Charoen, R.; Kansanabuch, T.; Tungsanga, K.; Eiam-Ong, S. 2006: Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose Journal of the Medical Association of Thailand 89(Suppl 2): S15-S20
Finkelstein, J.L.; Mehta, S.; Duggan, C.P.; Spiegelman, D.; Aboud, S.; Kupka, R.; Msamanga, G.I.; Fawzi, W.W. 2012: Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infections Public Health Nutrition 15(5): 928-937
El-Fiky, S.M.; Fahmy, T.Y.; Ameen, A.M. 1971: Morpho-topochemical studies of Golgi apparatus and Vitamin C in normal mammary gland cells of agent free C3Hf and agent carrying the MTV in C3H mouse strain Acta Histochemica 41(1): 131-136
van den Borne, B.E.; Landewé, R.B.; Goei The, H.S.; Rietveld, J.H.; Zwinderman, A.H.; Bruyn, G.A.; Breedveld, F.C.; Dijkmans, B.A. 1998: Combination therapy in recent onset rheumatoid arthritis: a randomized double blind trial of the addition of low dose cyclosporine to patients treated with low dose chloroquine Journal of Rheumatology 25(8): 1493-1498
Ferrando, R.; Fourlon, C. 1971: Influence of the intensity and duration of vitamin a deficiency on the storage of a large dose of this vitamin International Journal for Vitamin and Nutrition Research. Internationale Zeitschrift für Vitamin- und Ernahrungsforschung. Journal International de Vitaminologie et de Nutrition 41(4): 475-479
Underwood, B.A. 1980: Effect of protein quantity and quality on plasma response to an oral dose of vitamin A as an indicator of hepatic vitamin A reserves in rats Journal of Nutrition 110(8): 1635-1640
Wallace, G.; Howell, J.C.; Jodele, S.; Myers, K.C.; Dandoy, C.E.; El-Bietar, J.; Nelson, A.S.; Teusink-Cross, A.; Khandelwal, P.; Taggart, C.B.; Davies, S.M.; Lane, A.; Krupski, M.C. 2018: A Single Ultra High Dose of Vitamin D is Safe and Feasible in Early Peri-Transplant Period to Prevent Vitamin D Deficiency in Pediatric Hsct Recipients Biology of Blood and Marrow Transplantation 24(3): S286-S287
Dowling, R.D.; Zenati, M.; Burckart, G.J.; Yousem, S.A.; Schaper, M.; Simmons, R.L.; Hardesty, R.L.; Griffith, B.P. 1990: Aerosolized cyclosporine as single-agent immunotherapy in canine lung allografts Surgery 108(2): 198-204; Discussion: 204-205
Harbin, M.T.; Mooers, C.D.; Thomas, W.C. 1970: Automated phosphorus method employing ferrous sulfate as the reducing agent American Journal of Medical Technology 36(9): 425-429
Guirgis, F.K.; Habib, Y.A. 1971: Use of a new reducing agent, metamizol, in determining inorganic phosphorus in blood and urine Clinical Chemistry 17(2): 78-81
Rienks, A. 2000: Almost-tolerance halves cyclosporine dose Nephrology News and Issues 14(6): 42-43
Quesniaux, V.; Schreier, M.H.; Van Regenmortel, M.H. 1987: The potential of monoclonal antibodies for cyclosporine monitoring Transplantation Proceedings 19(1 Part 2): 1715-1716
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Rogerson, M.E.; Neild, G.H.; Rudge, C.J.; Wood, S.M.; Cairns, H.S.; Mansell, M.A.; Thompson, F.D. 1988: Renal transplants maintained on low-dose cyclosporine and prednisolone Transplantation Proceedings 20(3 Suppl 3): 114-116
Aso, K.; Uchida, H.; Sato, K.; Yokota, K.; Osakabe, T.; Nakayama, Y.; Ohkubo, M.; Kumano, K.; Endo, T.; Koshiba, K. 1987: Immunosuppression with low-dose cyclosporine combined with bredinin and prednisolone Transplantation Proceedings 19(1 Pt 3): 1955-1958
Keown, P.A. 1988: Optimizing cyclosporine therapy: dose, levels, and monitoring Transplantation Proceedings 20(2 Suppl 2: 382-389
Masri, M.; Naiem, M.; Daar, A.S. 1987: Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice Transplantation Proceedings 19(1 Part 2): 1212-1213